307989-04-4

Basic information

• Product Name: 3-{4-[1-(cis-4-tert-Butylcyclohexyl)-3-(4-trifluoromethoxyphenyl)ureidomethyl]-benzoylamino}propionic acid ethyl ester
• Synonyms: 3-{4-[1-(cis-4-tert-Butylcyclohexyl)-3-(4-trifluoromethoxyphenyl)ureidomethyl]-benzoylamino}propionic acid ethyl ester
• CAS NO: 307989-04-4
• Molecular Weight: 591.671
• Mol File: 307989-04-4.mol

Chemical Properties

• CAS DataBase Reference: 3-{4-[1-(cis-4-tert-Butylcyclohexyl)-3-(4-trifluoromethoxyphenyl)ureidomethyl]-benzoylamino}propionic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-{4-[1-(cis-4-tert-Butylcyclohexyl)-3-(4-trifluoromethoxyphenyl)ureidomethyl]-benzoylamino}propionic acid ethyl ester(307989-04-4)
• EPA Substance Registry System: 3-{4-[1-(cis-4-tert-Butylcyclohexyl)-3-(4-trifluoromethoxyphenyl)ureidomethyl]-benzoylamino}propionic acid ethyl ester(307989-04-4)

Safety Data

• Hazardous Substances Data: 307989-04-4(Hazardous Substances Data)

Downstream Products

• 307983-31-9 cis-3-{4-[1-(4-tert-butylcyclohexyl)-3-(4-trifluoromethoxyphenyl)ureidomethyl]benzoylamino}propionic acid 

Relevant articles and documents

Glucagon antagonists/inverse agonists

Disclosed is a novel class of compounds of formula (I) wherein V, A, Y, Z, R1, E, X and D are as defined in the specification. These compounds act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor, the compounds are suitable for treating or preventing glucagon-mediated conditions and diseases such as hyperglycemia, Type 1 diabetes, Type 2 diabetes and obesity.